Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.
| Filing date | Form | Description | View |
|---|---|---|---|
| S-1 | Registration statement for face-amount certificate companies |
||
| 424A | Substantive changes from or additions to a prospectus previously filed |
||
| S-1/A | Amended Registration statement for face-amount certificate companies |
||
| S-1/A | Amended Registration statement for face-amount certificate companies |
||
| 8-A12G | Registration of certain classes of securities 12(g) of the Securities Exchange Act |
||
| S-1/A | Amended Registration statement for face-amount certificate companies |
||
| S-1/A | Amended Registration statement for face-amount certificate companies |
||
| 424B1 | Form of prospectus that discloses information previously omitted from the prospectus |
||
| 10-Q | Quarterly report which provides a continuing view of a company's financial position |
||
| 10-Q | Quarterly report which provides a continuing view of a company's financial position |
Data provided by Kaleidoscope.